Page last updated: 2024-11-13

feglymycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

feglymycin: isolated from Streptomyces; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID25256761
MeSH IDM0333255

Synonyms (6)

Synonym
feglymycin
feglymicin (compound 30)
bdbm119091
209335-49-9
(2r)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-l-valyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-(2s)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-(2s)-2-(4-hydroxyphenyl)glycyl-(2r)-2-(3,5-dihydroxyphenyl)glycyl-l-valyl-(2r)-2
AKOS040756092

Research Excerpts

Overview

Feglymycin is a naturally occurring, anti-HIV and antimicrobial 13-mer peptide. It includes highly racemizable 3,5-dihydroxyphenylglycines (Dpgs)

ExcerptReferenceRelevance
"Feglymycin is a naturally occurring, anti-HIV and antimicrobial 13-mer peptide that includes highly racemizable 3,5-dihydroxyphenylglycines (Dpgs). "( Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation.
Fuse, S; Mifune, Y; Nakamura, H; Tanaka, H, 2016
)
2.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.00 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]